Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Enterprise Products Partners

Interpublic Group of Companies

iShares Russell 2000 ETF

Unum

Vale S.A.

Vodafone Group

Looking to build a long-term portfolio? Here are seven of the best dividend-paying stocks.

The 7 Best Dividend Stocks for Adventurous Investors

Ford Motor Company

General Electric

Starbucks

Over the past few months, we’ve seen an absolute roller-coaster of volatility in the markets, followed by a solid recovery, all due to the coronavirus pandemic.

Altria, Ford, GE, Starbucks and More Major Earnings Coming This Week

Johnson & Johnson

Coca-Cola

Realty Income Corp

The Federal Reserve has given another clear signal that there is less risk for investors, especially in long term.

Retirement Strategy: Blue Skies For Dividend Growth Investors, More Storms Ahead For Savers

Altria Group's (MO) second-quarter 2020 results are likely to reflect pricing gains. However, cigarette volumes have been affected by regulatory hurdles and rising health consciousness.

Here's How Altria (MO) is Placed Just Ahead of Q2 Earnings

Altria (MO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Altria (MO) Q2 Earnings Expected to Decline

Altria (MO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Can Altria (MO) Keep the Earnings Surprise Streak Alive?

Arrow Financial

Chubb

Diageo

Duke Energy

Con Ed

Genuine Parts

Lockheed Martin

Raytheon Technologies

AT&T

TC Energy

Travelers

Seven-hundred and seventy-three (773) companies have cut dividends in the first half of this extremely volatile year for stocks.

Build The Ultimate Sleep Well At Night Retirement Portfolio With These 15 High-Yield Blue-Chips

Altria's Upcoming Dividend Increase

Turning Point Brands

Vaping stocks have the potential to explode following recent controversy. Click for the companies best positioned to come out on top.

5 Vaping Stocks That Won’t Fold Under Federal Regulation

Chevron

High dividend yield stocks across sectors. These companies have robust cash flows and earnings growth visibility.

4 High-Yield Dividend Stocks to Buy to Ride Out the Storm

Altria: Grab This 8.4% Yield Dividend Aristocrat Right Now

Covering all the bases was expensive, but increased its chance of winning.

IQOS' Reduced-Risk Label Victory Shows Altria's Dual E-Cig Track Was the Smart Play

3 Reasons Altria Could Make You Rich

RICHMOND, Va.--(BUSINESS WIRE)---- $MO #1Hearnings2020--Altria Group, Inc. (Altria) (NYSE: MO) will host a live audio webcast on Tuesday, July 28, at 9:00 a.m. Eastern Time to discuss its 2020 second-quarter and first-half business results. Altria will issue a press release containing its business results at approximately 7:00 a.m. Eastern Time the same day. The webcast can be accessed at altria.com or through the Altria Investor App. During the webcast, Billy Gifford, Altria’s Chief Executive Officer, and Sal Mancuso

Altria to Host Webcast of 2020 Second-Quarter and First-Half Results

NEW YORK, July 14, 2020 /PRNewswire/ -- More smokers are trying to quit than ever before, making electronic cigarettes the most popular alternative to smoking in recent years. Major tobacco companies like Vector Group (NYSE:VGR), Altria Group (NYSE:MO), British American Tobacco...

Vape-related Deaths Turn Smokers Towards Alternative Quit Smoking Aids

Altria (MO) closed at $40.21 in the latest trading session, marking a -0.15% move from the prior day.

Altria (MO) Stock Moves -0.15%: What You Should Know

Bank of America

Federal Realty Investment Trust

Pfizer

Philip Morris

V.F.

WEC Energy Group

While some planning is required to successfully invest in dividend stocks, taking action to get started is just as important.

10 All Weather Dividend Stocks To Get You Started

MGM Resorts

Constellation Brands

Molson Coors Brewing

Consider these 5 names sin stocks to buy as 'shelter-in-place' winds down, and we 'return to normal, and all that entails, good and bad.
The post 5 Sin Stocks to Buy to Profit From Pent-Up Desires appeared first on InvestorPlace.

5 Sin Stocks to Buy to Profit From Pent-Up Desires

Canopy Growth

Cronos Group

Innovative Industrial Properties

Amplify Alternative Harvest ETF

Scotts Miracle-Gro

Yes, you can get paid while you wait for the high-growth cannabis industry to mature.

3 Ways to Collect a Dividend With Marijuana Stocks

RICHMOND, Va.--(BUSINESS WIRE)--Altria Group, Inc. (“Altria”) (NYSE:MO) today announced that its greenhouse gas emissions reduction targets have been approved for the first time by the Science Based Targets initiative (SBTi). The Scope 1 and 2 target covering greenhouse gas emissions from Altria’s operations is consistent with reductions required to keep warming to 1.5°C, a goal that the latest climate science says is needed to prevent the most damaging effects of climate change. The Scope 3 ta

Altria Recognized for Environmental Leadership

Altria stock lost more than 35% this year, declining from $49 to $31. However, it then increased by nearly 25%, from $31 to a little over $39 (as of July 6, 2020).

Altria Has Risks, But These Triggers Can Move The Stock Up

Universal Corp

Tobacco stocks burned brightly on Tuesday after a favorable FDA approval. Position for further gains with these trading ideas.

Tobacco Stocks Rise Amid IQOS Decision

RICHMOND, Va.--(BUSINESS WIRE)--Altria Group, Inc. (Altria) (NYSE: MO) announces today that the U.S. Food and Drug Administration (FDA) authorized the marketing of the IQOS tobacco heating system as a modified risk tobacco product with a reduced exposure claim. IQOS is the first next-generation inhalable tobacco product to be authorized as a modified risk tobacco product. Unlike cigarettes, the IQOS system heats but does not burn tobacco. Philip Morris USA (PM USA), under an exclusive licensing

FDA Authorizes Marketing of the IQOS Tobacco Heating System as a Modified Risk Tobacco Product

Problems with Juul continued to weigh on the Marlboro maker.

Why Altria Stock Lost 21% in the First Half of 2020

Altria: A Short-Term 'Diworsifier' That Could Still Deliver Long-Term Values

News for Altria Stock (MO)